Serum lipid levels in psoriasis

被引:56
作者
Piskin, S [1 ]
Gurkok, F
Ekuklu, G
Senol, M
机构
[1] Trakya Univ, Sch Med, Dept Dermatol, TR-22030 Edirne, Turkey
[2] Trakya Univ, Sch Med, Dept Publ Hlth, TR-22030 Edirne, Turkey
[3] Inonu Univ, Sch Med, Dept Dermatol, TR-44300 Malatya, Turkey
关键词
psoriasis; lipid; serum;
D O I
10.3349/ymj.2003.44.1.24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A predisposition to occlusive vascular diseases has been reported in patients with psoriasis and it has been suggested that some of these patients have some disorders of lipid metabolism. In this study, serum lipid levels were investigated in psoriatic patients to explore to the knowledge of this relationship. One hundred psoriatic patients and 100 non-psoriatic controls were included in the study. Total cholesterol, triglyceride, high-density lipoprotein-cholesterol (HDL-cholesterol), low-density lipoprotein-cholesterol (LDL-cholesterol), and very low-density lipoprotein-cholesterol (VLDL-cholesterol) levels were measured. In patients with psoriasis, total cholesterol and LDL-cholesterol levels were found to be significantly higher than those of controls. No significant differences were found in the other parameters. We concluded that psoriatic patients should be evaluated and followed up for the risk of hyperlipidemia and obstructive vascular diseases.
引用
收藏
页码:24 / 26
页数:3
相关论文
共 12 条
[1]  
Fortinskaia E S, 1996, Klin Lab Diagn, P38
[2]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[3]  
GURKOK F, 1999, B LEPROSY, V30, P105
[4]   PSORIASIS AND OCCLUSIVE VASCULAR-DISEASE [J].
MCDONALD, CJ ;
CALABRESI, P .
BRITISH JOURNAL OF DERMATOLOGY, 1978, 99 (05) :469-475
[5]   The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis [J].
Örem, A ;
Çimsit, G ;
Deger, O ;
Örem, C ;
Vanizor, B .
CLINICA CHIMICA ACTA, 1999, 284 (01) :81-88
[6]  
Pietrzak A, 1998, Ann Univ Mariae Curie Sklodowska Med, V53, P187
[7]  
PROKSCH E, 1995, HAUTARZT, V2, P76
[8]   Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease [J].
Rocha-Pereira, P ;
Santos-Silva, A ;
Rebelo, I ;
Figueiredo, A ;
Quintanilha, A ;
Teixeira, F .
CLINICA CHIMICA ACTA, 2001, 303 (1-2) :33-39
[9]   ARE LIPOPROTEIN PROFILE AND LIPOPROTEIN (A) LEVELS ALTERED IN MEN WITH PSORIASIS [J].
SECKIN, D ;
TOKGOZOGLU, L ;
AKKAYA, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (03) :445-449
[10]   SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH PSORIASIS [J].
SEISHIMA, M ;
SEISHIMA, M ;
MORI, S ;
NOMA, A .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 (06) :738-742